NCT05661331Active, not recruiting
VIATORR Device Registry
VIATORR Device Registry - Post-Market Clinical Follow-Up (PMCF) Registry of the GORE® VIATORR® TIPS Endoprosthesis With Controlled Expansion to Treat Portal Hypertension and Its Complications
Source: ClinicalTrials.gov · Last updated 7 Oct 2026
Brief summary (registry, in English)
The primary objective is to confirm the clinical performance and safety of the GORE® VIATORR® TIPS (Transjugular Intrahepatic Portosystemic Shunt) Endoprosthesis with Controlled Expansion throughout the device functional lifetime of 3 years in real world setting. The secondary objective is to collect information on quality of life after treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion. Additionally, data will be collected on the safety and performance of the GORE TIPS Set when utilized.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 196 (estimated)
- First submitted
- 29 Nov 2022
- Start date
- 21 Feb 2023
- Primary completion date
- 31 Mar 2028
- Lead sponsor
- W.L.Gore & Associates
- Diseases
- High blood pressure
- NCT number
- NCT05661331
What you commit to
- Study type: Observational
- Planned participants: 196
- From 21 Feb 2023 to the primary completion date, 31 Mar 2028
- 7 sites in 5 countries
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Patient has been previously enrolled in this registry
Other illness
- Any other condition which in the judgement of the investigator would preclude adequate registry participation
Other
- Unable or not willing to sign informed consent
- Patient is enrolled in an investigational study
- Pregnant or breastfeeding female at time of informed consent signature
Who the study is looking for
- Patient is eligible for treatment with the GORE® VIATORR® TIPS Endoprosthesis with Controlled Expansion for TIPS creation
- Patient is ≥18 years of age
- Capable of complying with protocol requirements, including follow-up
- Signed informed consent by patient
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (7)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Medical University of Vienna - Department of Internal Medicine III Coordinator of this site? Confirm its status | Vienna | Austria | Unknown status |
| University Medical Center Freiburg, Department of Medicine II Coordinator of this site? Confirm its status | Freiburg im Breisgau | Germany | Unknown status |
| Westfälische Wilhelms-Universität Münster Coordinator of this site? Confirm its status | Münster | Germany | Unknown status |
| Hospital Clinic Barcelona Coordinator of this site? Confirm its status | Barcelona | Spain | Unknown status |
| Hôpital La Pitié Salpetrière Coordinator of this site? Confirm its status | Paris | France | Unknown status |
| AOU Careggi Coordinator of this site? Confirm its status | Florence | Italy | Unknown status |
| University Hospital Modena Coordinator of this site? Confirm its status | Modena | Italy | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.